iMiCROQ is a 2010 spin‑off from Universitat Rovira i Virgili based in Tarragona that develops the QFast® analytical platform for integrated detection of pathogens, DNA, viruses and toxins. The company offers instrumentation packs and kits currently for detection of Salmonella spp. in veterinary, environmental and food samples, with Gen‑QFast® Listeria monocytogenes and QFast® Sakazakii kits undergoing certification. QFast® has been implemented in ISO 17025 accredited laboratories, internal control labs, poultry integrations, feed and raw‑material producers, animal health companies and SMEs in the food sector. The platform supports ELISA/ELONA‑type assays with technical advantages that reduce interference, handling and total time while improving sensitivity, enabling in‑situ diagnostic applications in veterinary and clinical areas. iMiCROQ has 14 employees and positions its commercial, marketing and product development activities to consolidate QFast® as a reference brand in rapid microbiological diagnostics. The company plans to expand its portfolio for agro‑food safety and advance international commercialization in the coming years. iMICROQ develops low-cost, integrated screen-printed microsystems for rapid detection and identification of pathogenic agents, including its QFast Salmonella kit. The company plans to use the funds to accelerate international validation activities and to run industrial and production tests to begin international commercialization of the Salmonella kit. It raised €1.1M in the reported funding round. iMICROQ was founded in 2010 and is based in Tarragona, Spain. The technology was developed at the University Rovira i Virgili’s Advanced Innovation Technology Centre (ATIC). The company was founded by Ioanis Katakis, Pablo Lozano, Diego Bejarano, Maria Viviana Duarte and Carlos Arias.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2017